APAC Radiotherapy Market - Industry Trends and Forecast to 2030
The Asia-Pacific radiotherapy market is projected to register a CAGR of 9.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
Asia Pacific Radiotherapy Market, By Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centres, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others), Country (China, Australia, Vietnam, Japan, India, New Zealand, Malaysia, South Korea, Singapore, Thailand, Indonesia, Philippines, and rest of Asia-Pacific) - Industry Trends and Forecast to 2030
Overview of Asia-Pacific Radiotherapy Market Dynamics
Driver
• Growing prevalence of cancer disease
Restraint
• Lack of skilled and certified professionals
Opportunity
• Increasing healthcare expenditure for cancer treatment
Market Players
Some of the major market players operating in the Asia-Pacific radiotherapy market are:
• VIEWRAY TECHNOLOGIES, INC. (A Subsidiary of ViewRay)
• Siemens Healthcare GmbH
• Elekta AB
• Accuray Incorporated
• IBA Worldwide
• Eckert & Ziegler BEBIG
• Brainlab AG
• Koninklijke Philips N.V.
• GE Healthcare
• Hitachi, Ltd.